Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Protagonist Therapeutics, Inc (PTGX)  
$76.72 0.78 (1.01%) as of 4:30 Mon 10/20


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 71,917,000
Market Cap: 5.52(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $35.09 - $87
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  446
Guru Rank Value     : 4.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protagonist Therapeutics is a clinical-stage biopharmaceutical company with various peptide-based new chemical entities in different stages of development, all derived from Co.'s proprietary technology platform. Co.'s clinical programs address two main categories of diseases; hematology and blood disorders, and inflammatory and immunomodulatory diseases. Co.'s main clinical asset, rusfertide (generic name for PTG-300) is an injectable hepcidin mimetic in development for the potential treatment of erythrocytosis, iron overload and other blood disorders. PN-943 is an investigational, orally delivered, gut-restricted alpha-4-beta-7 specific integrin antagonist for inflammatory bowel disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 82,859 104,615 377,595 626,042
Total Sell Value $4,924,058 $6,130,234 $18,360,530 $25,703,403
Total People Sold 2 4 5 5
Total Sell Transactions 7 10 21 35
End Date 2025-07-20 2025-04-18 2024-10-18 2023-10-19

   
Records found: 223
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Waddill William D. Director   –       •      –    2025-10-10 4 AS $69.25 $979,480 D/D (12,000) 5,130 -11%     
   Waddill William D. Director   –       •      –    2025-10-10 4 OE $6.98 $83,760 D/D 12,000 17,130     -
   Waddill William D. Director   –       •      –    2025-09-22 4 AS $64.25 $257,000 D/D (4,000) 5,130 20%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-09-16 4 GD $0.00 $0 D/D 620 519,983     -
   Waddill William D. Director   –       •      –    2025-08-27 4 AS $59.25 $237,000 D/D (4,000) 9,130 26%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-07-25 4 S $54.78 $570,534 D/D (10,415) 520,603 -41%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-07-23 4 S $54.79 $959,921 D/D (17,520) 531,018 -43%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-07-22 4 S $55.05 $1,214,678 D/D (22,065) 548,538 -41%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-07-21 4 S $54.86 $705,445 D/D (12,859) 570,603 -40%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-07-21 4 A $0.00 $0 D/D 25,000 583,462     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-07-16 4 GD $0.00 $0 D/D 5,000 558,462     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-06-16 4 GD $0.00 $0 D/D 685 562,905     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-06-13 4 GD $0.00 $0 D/D 670 563,590     -
   Molina Arturo Md Chief Medical Officer   •       –      –    2025-06-10 4 S $57.03 $570,300 D/D (10,000) 83,892 -37%     
   Molina Arturo Md Chief Medical Officer   •       –      –    2025-06-10 4 OE $8.04 $80,400 D/D 10,000 93,892     -
   Molina Arturo Md Chief Medical Officer   •       –      –    2025-06-09 4 S $55.51 $555,100 D/D (10,000) 83,892 -36%     
   Molina Arturo Md Chief Medical Officer   •       –      –    2025-06-09 4 OE $8.04 $80,400 D/D 10,000 93,892     -
   Selick Harold E Director   –       •      –    2025-04-28 4 OE $1.16 $12,441 D/D 10,725 43,851     -
   Ali Asif Chief Financial Officer   •       –      –    2025-04-22 4 S $46.00 $80,776 D/D (1,756) 61,065 -29%     
   Waddill William D. Director   –       •      –    2025-03-17 4 AS $54.25 $217,000 D/D (4,000) 13,130 4%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-03-05 4 OE $4.21 $101,040 D/D 24,000 564,260     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-02-19 4 S $38.18 $204,607 D/D (5,359) 540,260 -43%     
   Molina Arturo Md Chief Medical Officer   •       –      –    2025-01-16 4 S $0.00 $0 D/D (3,640) 83,892 -25%     
   Ali Asif Chief Financial Officer   •       –      –    2025-01-16 4 S $0.00 $0 D/D (3,918) 62,821 -25%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2025-01-15 4 D $0.00 $0 D/D (12,636) 545,619     -

  223 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed